Introduction. Rotational thromboelastometry (ROTEM) 
Introduction
Rotational Thromboelastometry (ROTEM) graphically represents the fibrin polymerization process in a thromboelastogram and provides a complete evaluation of the process of clot initiation, formation, and stability. (1) The original one-trace ROTEM was recently upgraded with the addition of new different coagulation-inducing agents and platelet-inhibiting agents, which allow detection of specific coagulation defects like hypofibrinogenemia, factor deficiency, thrombocytopenia, heparin influence and hyperfibrinolysis. (2, 3) The causes of bleeding in patients undergoing cardiac surgery on cardiopulmonary bypass are multifactorial, and involve hemodilution, anticoagulation (heparin), activation of coagulation and fibrinolytic systems and impairment of platelet function. (4) ROTEM provides a tool to specifically asses some of these changes and furthermore, it is a faster method than standard laboratory tests of coagulation. (5, 6) First results with ROTEM can be obtained within 10-30 minutes. (1,7) ROTEM has already been successfully used as a point of care test in adult cardiac surgery (2, 8, 9) and there is growing evidence of its usefulness in paediatric cardiac surgery. (4, 7, (10) (11) (12) Since the coagulation system in infants and neonates has some unique characteristics (4, 13, 14) and the data about thromboelastometry in infants and neonates after cardiac surgery are scarce, we decided to asses ROTEM abnormalities in neonates and infants undergoing cardiac surgery.
Methods
Infants and neonates undergoing cardiac surgery on cardiopulmonary bypass between May 2011 and January 2012, and postoperatively admitted to a level III, multidisciplinary neonatal and paediatric intensive care unit (ICU), were included in this prospective, observational study. Infants and neonates with previously known coagulopathies or thrombocytopathies were excluded from the study. The study protocol encompassing patient data and surgery data was completed for each patient. Administration of blood products and the amount of bleeding were recorded hourly during the first 24h. Blood samples for ROTEM ® analysis were obtained before surgery (t 1 ), after admission to ICU (t 2 ) and 24 hours after surgery (t 3 ) together with platelet count, international normalized ratio of prothrombin time (INR), activated partial thromboplastin time (PTT), and fibrinogen concentration. 
Results
Twenty infants and neonates were operated on during the time of the study. The patients' characteristics are summarized in 
Discussion
Cardiac surgery on cardiopulmonary bypass can affect different aspects of coagulation. (15) (16) (17) Although most of the ROTEM parameters showed significant deterioration following surgery, thrombocytopenia was the predominant ROTEM abnormality seen in our group of neonates and infants. Straub et al. found in 10 infants undergoing cardiac surgery on cardiopulmonary bypass prolongation of CT in INTEM and HEPTEM and a decrease in INTEM, HEPTEM, EXTEM and FIBTEM amplitude which represented a measure for clot firmness and is similar to our MCF. (7) The authors concluded that these changes reflected the defect in plasmatic coagulation together with platelet damage. (7) In our group of patients CT was significantly prolonged after admission to ICU (t 2 ) in comparison to baseline (t 1 ), but the median CT result in all ROTEM tests was still within normal range according to our reference values. This shows that a plasmatic coagulation defect was not the most important cause of bleeding in our patients. Meanwhile, prolongation of median CFT in INTEM and HEPTEM, when compared to our reference values, together with reduction of median MCF in all ROTEM tests except FIBTEM, were found in our patients after admission to ICU (t 2 ). In addition, significant prolongation of CFT and reduction of MCF in all ROTEM tests were found in our patients after admission to ICU (t 2 ). Since CFT and MCF, except from factor XIII, are mainly based on platelets and fibrinogen, and furthermore, fibrinogen dysfunction can be excluded with FIBTEM-MCF in the normal range, we concluded that the most important cause of bleeding in our patients was thrombocytopenia. This finding was also supported by lowered median platelet count after surgery (t 2 (4) , in the first 24h, was very similar to ours, but they used far less blood products than we did. We used fresh frozen plasma in the majority of our patients, which explains the return of CT toward baseline values (t 1 ) in our patients 24h after surgery (t 3 ), despite bleeding. (19) we found no differences between infants receiving PGE 1 and those without PGE 1 before surgery (t 1 ) and after admission to ICU (t 2 ). Since platelet function cannot be measured by ROTEM, the specific tests for platelet function should be used to measure the influence of PGE 1 on platelets. (20) Shortened EXTEM-CT in infants receiving PGE 1 24h after surgery (t 3 ) can be explained by the comparatively younger age of infants receiving PGE 1 and by the already described "hypercoagulability state" in the first three months of life. (14, 18) In conclusion, cardiac surgery on cardiopulmonary bypass in our neonates and infants predominantly affected platelets, although most of the ROTEM parameters deteriorated. ROTEM might be especially useful in evaluation of neonates and infants after cardiac surgery on cardiopulmonary bypass, who bleed excessively and in whom standard therapy in our ICU (packed red blood cells and fresh frozen plasma) is insufficient.
